IPO Trending
BMLLSME / NSEListed

Bio Medica Laboratories Limited

Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.

₹132 - ₹1392.31x sub
Listed Price111.20
Listing Gain-20.00%
Subscription2.31x total demandUpdated 29 May 2026, 04:15 AM
QIB15.94x
Hot Bidding (High Profits)Offered: 36,000 sh
Nib1.41x
Fully Subscribed (Safe)Offered: 17,55,000 sh
Hnis(10l +)1.02x
Fully Subscribed (Safe)Offered: 11,70,000 sh
Hnis (2-10l)2.19x
Fully Subscribed (Safe)Offered: 5,85,000 sh
Retail2.92x
Fully Subscribed (Safe)Offered: 17,92,000 sh
CategoryOfferedAppliedTimes
QIB36,0005,74,00015.94x
Nib17,55,00024,75,0001.41x
Hnis(10l +)11,70,00011,93,0001.02x
Hnis (2-10l)5,85,00012,82,0002.19x
Retail17,92,00052,28,0002.92x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB7.980.515.96x
Fiis7.980Open
Retail72.6724.912.92x
Hnis 2+17.828.132.19x
Hnis 10+16.5816.261.02x
Application-wise Breakup
CategoryReservedAppliedTimes Sub.
QIB06Open
Nib0457Open
Retail8962,6142.92x
Hnis(10l +)390350.09x
Hnis (2-10l)1954222.16x